Sands Capital Ventures »

Bioage Labs shares owned by Sands Capital Ventures

Quarter-by-quarter ownership of Bioage Labs shares owned by Sands Capital Ventures from 13F filings

Historical chart of Sands Capital Ventures investment in Bioage Labs

Tip: Access up to 7 years of quarterly data

All positions including Bioage Labs held by Sands Capital Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioage Labs by Sands Capital Ventures

Quarter filed Position value Share count Share price at filing
2024-09-30 $23M 1.1M 20.80

More positions owned by Sands Capital Ventures

Klaviyo Com Ser A (KVYO)
Nu Hldgs Ord Shs Cl A (NU)
Doordash Cl A (DASH)
Bioage Labs
Acrivon Therapeutics Common Stock (ACRV)
Uipath Cl A (PATH)
Snowflake Cl A (SNOW)
10x Genomics Cl A Com (TXG)
Acumen Pharmaceuticals (ABOS)
Tarsus Pharmaceuticals (TARS)
Candel Therapeutics (CADL)
Taysha Gene Therapies Com Shs (TSHA)
908 Devices (MASS)
Spruce Biosciences (SPRB)
Coupang Cl A (CPNG)

View all positions for Sands Capital Ventures

Top funds holding Bioage Labs

AH Capital Management
Sofinnova Ventures
RA Capital Management
OrbiMed Advisors
Sands Capital Ventures
Pivotal bioVenture Partners Investment Advisor
T. Rowe Price Associates
Redpoint Management
Siren
Emerald Advisers
Daniel D. Thurber
Emerald Mutual Fund Advisers, Trust
Citadel Advisors
Jpmorgan Chase & Co
Marshall Wace

View all funds holding Bioage Labs